HWKN HAWKINS INC

Nasdaq hawkinsinc.com


$ 161.69 $ -6.33 (-3.77 %)    

Friday, 17-Oct-2025 15:59:53 EDT
QQQ $ 604.85 $ 3.94 (0.66 %)
DIA $ 461.79 $ 2.22 (0.48 %)
SPY $ 665.25 $ 3.75 (0.57 %)
TLT $ 91.11 $ -0.14 (-0.15 %)
GLD $ 390.99 $ -7.46 (-1.88 %)
$ 161.75
$ 166.81
$ 150.01 x 1
$ 172.17 x 1
$ 158.45 - $ 167.84
$ 98.06 - $ 186.15
212,835
na
3.38B
$ 0.89
$ 40.04
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-30-2025 06-29-2025 10-Q
2 05-14-2025 03-30-2025 10-K
3 01-29-2025 12-29-2024 10-Q
4 10-30-2024 09-29-2024 10-Q
5 07-31-2024 06-30-2024 10-Q
6 05-15-2024 03-31-2024 10-K
7 01-31-2024 12-31-2023 10-Q
8 11-01-2023 10-01-2023 10-Q
9 08-02-2023 07-02-2023 10-Q
10 05-17-2023 04-02-2023 10-K
11 02-01-2023 01-01-2023 10-Q
12 11-02-2022 10-02-2022 10-Q
13 08-04-2022 07-03-2022 10-Q
14 05-18-2022 04-03-2022 10-K
15 02-02-2022 12-26-2021 10-Q
16 10-27-2021 09-26-2021 10-Q
17 07-29-2021 06-27-2021 10-Q
18 06-02-2021 03-28-2021 10-K
19 01-28-2021 12-27-2020 10-Q
20 10-21-2020 09-27-2020 10-Q
21 07-31-2020 06-28-2020 10-Q
22 05-20-2020 03-29-2020 10-K
23 02-06-2020 12-29-2019 10-Q
24 10-30-2019 09-29-2019 10-Q
25 07-31-2019 06-30-2019 10-Q
26 05-23-2019 03-31-2019 10-K
27 02-06-2019 12-30-2018 10-Q
28 10-31-2018 09-30-2018 10-Q
29 08-02-2018 07-01-2018 10-Q
30 05-31-2018 04-01-2018 10-K
31 02-08-2018 12-31-2017 10-Q
32 11-02-2017 10-01-2017 10-Q
33 08-09-2017 07-02-2017 10-Q
34 06-01-2017 04-02-2017 10-K
35 02-09-2017 01-01-2017 10-Q
36 11-02-2016 10-02-2016 10-Q
37 08-04-2016 07-03-2016 10-Q
38 06-03-2016 04-03-2016 10-K
39 02-05-2016 12-27-2015 10-Q
40 10-28-2015 09-27-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 bws-financial-maintains-buy-on-hawkins-raises-price-target-to-200

BWS Financial analyst Hamed Khorsand maintains Hawkins (NASDAQ:HWKN) with a Buy and raises the price target from $160 to $200.

 hawkins-q1-eps-140-beats-134-estimate-sales-29327m-beat-27876m-estimate

Hawkins (NASDAQ:HWKN) reported quarterly earnings of $1.40 per share which beat the analyst consensus estimate of $1.34 by 4.63...

 earnings-outlook-for-hawkins
Earnings Outlook For Hawkins
07/29/2025 19:03:12

 raymond-james-initiates-coverage-on-hawkins-with-market-perform-rating

Raymond James analyst Bobby Zolper initiates coverage on Hawkins (NASDAQ:HWKN) with a Market Perform rating.

 bws-financial-maintains-buy-on-hawkins-maintains-160-price-target

BWS Financial analyst Hamed Khorsand maintains Hawkins (NASDAQ:HWKN) with a Buy and maintains $160 price target.

 hawkins-q4-eps-078-beats-073-estimate-sales-24532m-beat-23069m-estimate

Hawkins (NASDAQ:HWKN) reported quarterly earnings of $0.78 per share which beat the analyst consensus estimate of $0.73 by 6.85...

 earnings-outlook-for-hawkins
Earnings Outlook For Hawkins
05/13/2025 15:01:16

 hawkins-completes-acquisition-of-assets-of-surplus-management-doing-business-as-watersurplus

Key financial highlights:The Company also closed on an amended $400 million revolving credit facility with U.S. Bank National A...

 bws-financial-upgrades-hawkins-to-buy-announces-160-price-target

BWS Financial analyst Hamed Khorsand upgrades Hawkins (NASDAQ:HWKN) from Neutral to Buy and announces $160 price target.

 bws-financial-maintains-neutral-on-hawkins-maintains-122-price-target

BWS Financial analyst Hamed Khorsand maintains Hawkins (NASDAQ:HWKN) with a Neutral and maintains $122 price target.

 earnings-summary-hawkins-q3
Earnings Summary: Hawkins Q3
01/29/2025 21:35:22

 hawkins-q3-2024-gaap-eps-072-misses-092-estimate-sales-22621m-beat-21922m-estimate

Hawkins (NASDAQ:HWKN) reported quarterly earnings of $0.72 per share which missed the analyst consensus estimate of $0.92 by 21...

 bws-financial-maintains-neutral-on-hawkins-maintains-122-price-target

BWS Financial analyst Hamed Khorsand maintains Hawkins (NASDAQ:HWKN) with a Neutral and maintains $122 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION